Background: Hyponatremia (serum sodium concentration < 135 mmol/L) represents the most common electrolyte disturbance in clinical practice, particularly among high-risk populations such as older adults. Its severity ranges from moderately severe to life-threatening symptoms, contributing to increased mortality. Its etiology is widely heterogeneous and leads to different classifications according to volume status such as hypovolemic, euvolemic and hypervolemic hyponatremia. Drug-induced hyponatremia presents itself as one of the most prevalent but frequently overlooked causes, since many confounding factors like associated comorbidities and polypharmacy complicate the identification of specific medicines as the main offenders. Objectives: This narrative review was performed to provide a comprehensive analysis on drug-induced hyponatremia, focusing not only on the underlying pharmacological mechanisms, but also on management strategies in clinical practice. Methods: A narrative literature review was conducted using PubMed, Science Direct and Google Scholar. Results: This narrative review focused not only on the most common drug classes to induce hyponatremia through different mechanisms, including diuretics, antidepressants, anticonvulsants, and antipsychotics, but also on other pharmacological classes, that, although to a lesser extent, might also be associated with decreasing serum sodium levels (antineoplastic and immunomodulating agents, drugs acting on digestive and locomotor systems, anti-infective drugs, endocrine diseases drugs, among others). It also explores recommendations on the management of drug-induced hyponatremia and it emphasizes the role of healthcare providers in addressing this electrolyte disorder. Conclusions: As drug-induced hyponatremia poses significant challenges in clinical practice, understanding its mechanisms, coupled with effective management strategies, can enhance patient safety.
3 November 2026 in WORK: A Journal of Prevention, Assessment & Rehabilitation
Background: Burnout syndrome, characterized by emotional exhaustion, reduced personal accomplishment, and detachment, affects personal and professional well-being. Humor-based interventions have been explored as strategies to promote psychological resilience. Objective: To assess the impact of a humor-based intervention combined with team-building sessions on burnout levels among professionals in a Family Health Unit. Methods: Controlled before-after study in two Family Health Units. The intervention group comprised 6 physicians, 6 nurses and 4 secretaries; the control group 5 physicians, 5 nurses and 4 secretaries. Median age was 47.5 years (IQR 19.25) in the control and 50.0 years (IQR 11.75) in the intervention group; 76.7% were female. At baseline and post-intervention, participants completed the Multidimensional Sense of Humor Scale, the Copenhagen Burnout Inventory—Portuguese version, and the Personal Wellbeing Index—Adult. Over one year, intervention group staff participated in weekly humor-viewing sessions and two psychologist-led workshops on communication skills and burnout prevention. The primary outcome was change in burnout across three domains (personal, work-related, patient-related); the secondary outcome was subjective well-being. Results: A statistically significant between-group difference in patient-related burnout was found at post-intervention: scores increased in the control group and decreased in the intervention group (p = 0.04). Within-group pre—post changes were not statistically significant, and no significant differences were observed in the remaining burnout domains or in well-being. Conclusions: The intervention was associated with lower patient-related burnout. Despite limitations in sample size and study design, findings suggest potential benefits of humor-based approaches in healthcare.
Introdução: Os doentes com síndroma de apneia obstrutiva do sono (SAOS) sob ventiloterapia, após alta da consulta hospitalar, devem manter o seguimento nos cuidados de saúde primários, para monitorização terapêutica. Objetivos: Melhorar o seguimento de doentes com SAOS sob ventiloterapia e sem acompanhamento hospitalar, numa Unidade de Saúde Familiar (USF). Outcome secundário: avaliação do número de referenciações hospitalares por terapêutica ineficaz/baixa adesão. Métodos: Estudo quasi-experimental, pré-pós intervenção, numa USF. Foram identificados doentes com diagnóstico de Perturbação do Sono (P06 – ICPC2), com SAOS, sob ventiloterapia, sem seguimento em consulta hospitalar. Analisados os dados do processo clínico relativos a interpretação de relatório de ventiloterapia, realização de consulta de seguimento e referenciação hospitalar. A primeira avaliação incidiu sobre o período entre janeiro e dezembro/2019. Posteriormente foram realizadas sessões formativas, com envolvimento da equipa multiprofissional. Desenvolvido procedimento de atuação para otimizar o pedido de relatórios por parte da equipa administrativa. Fornecido material auxiliar de memória e criada pasta informática com guião de seguimento de utentes, documento modelo para solicitação de relatório e panfleto sobre SAOS. A segunda avaliação incidiu sobre janeiro e dezembro/2021. Foram estabelecidas as seguintes metas, após discussão em reunião médica: taxa de consultas de seguimento ≥20%; taxa de interpretação de relatórios de ventiloterapia ≥20%. Resultados: Na primeira avaliação não se verificou a realização de consultas de seguimento de SAOS na USF. Em 2021 atingiu-se uma taxa de interpretação de relatórios de ventiloterapia de 25,47%, uma taxa de consultas de seguimento de 15,09% e foram realizadas cinco referenciações hospitalares por terapêutica inadequada. Conclusões: Apesar da meta definida para consultas de seguimento não ter sido atingida, este estudo promoveu o envolvimento de toda a equipa multiprofissional e a implementação de uma estratégia simples de acompanhamento e otimização terapêutica de doentes com SAOS na USF.
Introduction and objectives: During the COVID-19 pandemic, the follow-up of patients treated with vitamin K antagonists (VKAs) may have been affected. This study aims to compare how these patients were monitored preand post-COVID-19 pandemic and understand the impact of non-face-to-face appointments on their follow-up. Methods: We conducted a retrospective cohort study in a Portuguese Health Center. The study included patients treated with VKAs and followed at the Health Center for international normalized ratio (INR) monitoring between March 2019 and March 2021. Data collected: sex, age, type of VKA; INR; date of INR assessment, type of appointment (face-to-face or phone/e-mail). Rosendaal’s method was used to calculate pre-COVID-19 and post-COVID-19 time in therapeutic range (TTR). Good TTR control was defined if values ≥ 70%. Results: 44 patients were included. The mean TTR in the pre-COVID-19 period was 64.55% (95% CI: 58.10 - 71.00%). The post-COVID-19 mean was slightly higher (+ 2.26%), 66.81% (95% CI: 59.66 - 73.97%), but the difference was not statistically significant (p = 0.576). The use of non-face-to-face appointments did not contribute to worsening post-pandemic TTR, showing no lower follow-up than during pre-pandemic period in which all contacts were face-to-face [CI (95%) -0.397 - 0.196 for a reference range -0.489 - 0.693]. Conclusions: The TTR value in both periods was similar and lower than the value defined for effective hypocoagulation. The use of non-face-to-face consultation in the post-COVID-19 period does not seem to have influenced the quality of hypocoagulation.